Transforming growth factor-beta in disease: the dark side of tissue repair.
about
Lupus nephritis: current updateInteraction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor betaCirrhosis: new research provides a basis for rational and targeted treatmentsCell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesisBetaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sitesHIV-1 gp160 protein-macrophage interactions modulate mesangial cell proliferation and matrix synthesisDecorin: A Growth Factor Antagonist for Tumor Growth InhibitionSystemically Administered, Target Organ-Specific Therapies for Regenerative MedicineMyeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in micePivotal role for decorin in angiogenesis'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery diseasePolarity of response to transforming growth factor-beta1 in proximal tubular epithelial cells is regulated by beta-cateninFetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonistRecombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agentDiesel exhaust (DE)-induced cytokine expression in human bronchial epithelial cells: a study with a new cell exposure system to freshly generated DE in vitroHeart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryosTumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexiaRat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alphaChanges of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysisCellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetesHypertrophic scar formation following carbon dioxide laser ablation of plantar warts in cyclosporin-treated patients.Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications.Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.Exploring hypotheses of the actions of TGF-beta1 in epidermal wound healing using a 3D computational multiscale model of the human epidermisPlasma TGF beta in systemic sclerosis: a cross-sectional study.Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) miceCardiovascular aging research: the next horizons.Activation of a serine/threonine kinase signaling pathway by transforming growth factor type betaAirway wall remodelling: does it occur and what does it mean?PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling.Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function.Inhibitory effects of rapamycin on the different stages of hepatic fibrosisAutocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Stromal fibroblast activation and their potential association with uterine fibroids (Review).Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat.A major advance in the use of growth factors to enhance wound healing.In vivo gene transfer, Koch's postulates, and renal disease.Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesionsAntibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
P2860
Q22000837-192A2FAF-A7BA-41A4-9F68-02FC8552AB06Q24321274-F32BF678-FC9D-4F97-B875-2EAD44F7AA75Q24527263-C09DB716-DAF8-40A1-8E01-3FC38DEC0DE5Q24610450-B545D12F-39F4-47E5-8D39-C3222A6F127FQ24673586-F8A18E71-B2DF-4796-80C4-D2DF50AED7F7Q24684106-4B6D5CE8-F96F-4217-BF66-F8A594EED45EQ26772197-DA674A44-F7B4-49C7-B9DE-161C98285C9DQ26782082-33AEE0BE-F88F-452C-AE72-750DFBD81DDFQ27308666-BDAAB9E8-4A14-463E-8717-1C7AAE106759Q28085303-CA6C249A-AC31-427A-8023-48AB67E4BAC8Q28218832-63C250EB-6F6A-45F4-A53B-E1508E667E87Q28236038-8DD37429-B2B4-4657-85F2-C06B7245A9EAQ28281644-BC627563-6075-4602-B2E0-87C656686736Q28360679-20157BB8-B8A4-4126-9953-30E2F68D0067Q28371941-81721EB6-49C4-490D-AE54-D408A472F614Q28508310-7BF4545F-C751-41E6-9E06-53546DAAA2DDQ28508850-9F472B2C-4FD5-4BA2-8ABA-D57F39E19AEFQ28581501-931BC920-DA3A-4586-B419-8FEFE779C579Q29994602-8FFA43D4-127E-4CDD-8EFE-5556233E7545Q30419393-1028E0A5-424E-4444-B612-7534C60C5AD6Q30700092-1601B620-A5E1-4815-BC90-1CEAF3DF699EQ31866703-734CF3BA-78C8-4B09-82F7-48451B45747FQ33198923-5BB8AB2C-7E0D-445F-B074-EB97F1BDC0A2Q33521712-080E8F69-2958-4911-8E60-41D5186C7727Q33566799-B2B889D0-38F3-49C3-9FA9-B3C99E7C67A5Q33590493-0E992196-762F-46FC-B76A-F624ECBA1285Q33633405-20698060-6DFF-4BA0-A0C8-254683DDB5A0Q33648491-DA5F8D52-5D55-45F7-91E8-35C630E587BFQ33751283-D3615C6B-DBA3-4EBE-80AC-B3367EC92277Q33756992-39041EDA-91A3-4F57-9351-3300AC6E4D69Q33761949-847C9B55-5E02-41E2-8A90-784DD8F008C5Q33780195-FCD3B1D1-7D8D-4988-9B89-9176450A439CQ33793187-693F7C16-6831-4DAB-B15A-574E753E0446Q33844177-C6560213-3D71-4CA5-9921-805A2855EA4DQ33902166-6726DDC4-E37E-47BC-BCDA-4DB058EA31E2Q33904817-A94A64F8-DCCA-48F9-81C1-5613CDCF4B74Q33909394-790ED8A8-D295-45D1-A31E-9900609CD2EBQ33909447-9C23094B-C4CA-41F4-8B58-0F6A6E3A41F9Q33919124-3CC8F86C-E5CE-440B-95B5-917C853E626FQ34133039-BBCD0D0B-3F6C-4690-84C1-9476C9C74CE3
P2860
Transforming growth factor-beta in disease: the dark side of tissue repair.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Transforming growth factor-beta in disease: the dark side of tissue repair.
@ast
Transforming growth factor-beta in disease: the dark side of tissue repair.
@en
type
label
Transforming growth factor-beta in disease: the dark side of tissue repair.
@ast
Transforming growth factor-beta in disease: the dark side of tissue repair.
@en
prefLabel
Transforming growth factor-beta in disease: the dark side of tissue repair.
@ast
Transforming growth factor-beta in disease: the dark side of tissue repair.
@en
P2860
P356
P1476
Transforming growth factor-beta in disease: the dark side of tissue repair.
@en
P2093
E Ruoslahti
W A Border
P2860
P356
10.1172/JCI115821
P407
P577
1992-07-01T00:00:00Z